Travere Therapeutics Inc (RTRX) Ownership

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Travere Therapeutics Inc (RTRX), owning a total of 4.7 million shares. Combined, the top 20 institutional holders of RTRX own 76.58% of the company with a total of 39.1 million shares.

In the latest ownership report on September 30th 2020, the top 20 institutional holders increased their combined ownership of RTRX by 127 thousand shares. 5 institutions bought 889,194 total additional shares and increased their ownership by an average of 9.22%. However 4 institutions sold 761,947 total shares and decreased their ownership by an average of 13.8%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Travere Therapeutics increased by a net total of 127,247 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc9.285%5.571%4,739,933250,1062020-09-30
Vanguard Group Inc6.313%8.482%3,222,832251,9882020-09-30
Manufacturers Life Insurance Co4.331%1.366%2,211,14129,7912020-09-30
State Street Corporation3.762%4.478%1,920,41582,3092020-09-30
Adage Capital Partners Gp LLC3.006%-6.118%1,534,500-100,0002020-09-30
Scopia Management Inc2.609%-25.408%1,332,150-453,7592020-09-30
venBio Select Advisor LLC2.595%26.191%1,325,000275,0002020-09-30
Dimensional Fund Advisors, Inc.2.351%-1.672%1,200,266-20,4142020-09-30
FMR Inc1.594%0.000%813,69902020-09-30
Goldman Sachs Group Inc1.303%-22.017%665,075-187,7742020-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc9.285%5.571%4,739,933250,1062020-09-30
RA Capital Management, LLC9.080%11.262%4,635,687469,2342020-06-30
Macquarie Group Ltd6.873%4.495%3,508,928150,9272020-06-30
Perceptive Advisors LLC6.347%12.091%3,240,112349,5042020-06-30
Vanguard Group Inc6.313%8.482%3,222,832251,9882020-09-30
Manufacturers Life Insurance Co4.331%1.366%2,211,14129,7912020-09-30
Renaissance Technologies Corp3.876%65.041%1,978,488779,7002020-06-30
State Street Corporation3.762%4.478%1,920,41582,3092020-09-30
D. E. Shaw & Co LP3.493%12.392%1,783,132196,6012020-06-30
Adage Capital Partners Gp LLC3.006%-6.118%1,534,500-100,0002020-09-30
Bank of America Corp2.758%-2.147%1,408,208-30,8902020-06-30
Scopia Management Inc2.609%-25.408%1,332,150-453,7592020-09-30
venBio Select Advisor LLC2.595%26.191%1,325,000275,0002020-09-30
Dimensional Fund Advisors, Inc.2.351%-1.672%1,200,266-20,4142020-09-30
Millennium Management LLC2.350%6.383%1,199,86171,9872020-06-30
Rock Springs Capital Management LP2.006%78.132%1,024,261449,2612020-06-30
FMR Inc1.594%0.000%813,69902020-09-30
Jacobs Levy Equity Management, Inc.1.340%14.062%684,24684,3552020-06-30
Geode Capital Management, LLC1.308%1.171%667,6607,7292020-06-30
Goldman Sachs Group Inc1.303%-22.017%665,075-187,7742020-09-30

Mutual Fund Ownership

Macquarie US Small Cap Core Equity is the biggest individual fund holder of Travere Therapeutics Inc (RTRX), owning a total of 2.5 million shares. Combined, the top 20 mutual fund holders of RTRX own 33.99% of the company with a total of 17.4 million shares.

In the latest ownership report on December 31st 2020, the top 20 fund holders increased their combined ownership of RTRX by 10 thousand shares. 1 funds bought 2,632 total additional shares and increased their ownership by an average of 0.36%. However 2 funds sold 12,594 total shares and decreased their ownership by an average of 0.99%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Travere Therapeutics decreased by a net total of -9,962 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Russell 2000 ETF2.257%-0.519%1,152,135-6,0142020-12-31
SPDR® S&P Biotech ETF1.442%0.359%736,3702,6322020-12-31
iShares Russell 2000 Growth ETF0.898%0.000%458,36702020-12-31
iShares Nasdaq Biotechnology ETF0.869%-1.461%443,826-6,5802020-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Macquarie US Small Cap Core Equity4.936%-8.157%2,519,680-223,7802020-09-30
Delaware Small Cap Core I4.474%-9.352%2,284,040-235,6402020-11-30
Vanguard Total Stock Mkt Idx Inv2.741%0.734%1,399,44810,1982020-11-30
iShares Russell 2000 ETF2.257%-0.519%1,152,135-6,0142020-12-31
Janus Henderson Global Life Sciences2.248%-0.423%1,147,825-4,8792020-09-30
Janus Henderson Global Life Sciences D2.248%-0.423%1,147,825-4,8792020-09-30
Janus Henderson Glb Life Scn I2 USD1.672%5.215%853,51042,3042020-11-30
Fidelity® Select Biotechnology1.594%0.000%813,699813,6992020-11-30
SPDR® S&P Biotech ETF1.442%0.359%736,3702,6322020-12-31
HBM Healthcare Investments AG Ord1.409%-26.147%719,482-254,7322020-09-30
Janus Henderson Venture D1.236%0.000%630,773630,7732020-09-30
Janus Henderson US Small Cap Growth1.236%0.000%630,773630,7732020-09-30
Vanguard Extended Market Index Investor1.215%-0.859%620,030-5,3702020-11-30
iShares Russell 2000 Growth ETF0.898%0.000%458,36702020-12-31
iShares Nasdaq Biotechnology ETF0.869%-1.461%443,826-6,5802020-12-31
TIAA-CREF Quant Small-Cap Equity Instl0.826%-1.725%421,566-7,4002020-11-30
DFA US Small Cap I0.802%-3.354%409,323-14,2052020-11-30
BlackRock Health Sciences Trust II0.773%0.000%394,67402020-09-30
Vanguard Explorer Inv0.562%166.643%287,030179,3842020-09-30
MEDICAL BioHealth EUR0.556%0.000%283,571283,5712020-11-30

Discussions

Please log in or register to share your thoughts.

easymoneyFAM11/26/23 04:02pm

$RTRX I'm not afraid.
I'm long
And I'm strong..........

0 Like Report
aussie71311/8/23 06:13am

$RTRX can’t wait to get in this tomorrow lfg

0 Like Report
145zip3/30/23 10:00am

$RTRX this market love evrry dips let’s see

0 Like Report
bulls_only1/23/23 12:33pm

$RTRX Markets about as efficient as a retirement home

0 Like Report